C. Busi

1.2k total citations
45 papers, 890 citations indexed

About

C. Busi is a scholar working on Molecular Biology, Hepatology and Epidemiology. According to data from OpenAlex, C. Busi has authored 45 papers receiving a total of 890 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 14 papers in Hepatology and 10 papers in Epidemiology. Recurrent topics in C. Busi's work include Glycosylation and Glycoproteins Research (15 papers), Hepatitis B Virus Studies (7 papers) and Biochemical and Molecular Research (6 papers). C. Busi is often cited by papers focused on Glycosylation and Glycoproteins Research (15 papers), Hepatitis B Virus Studies (7 papers) and Biochemical and Molecular Research (6 papers). C. Busi collaborates with scholars based in Italy, Germany and Czechia. C. Busi's co-authors include L. Fiume, A Mattioli, Giuseppina Di Stefano, Pier Giorgio Balboni, G. Barbanti‐Brodano, Felix Kratz, Pasquale Chieco, Luigi Bolondi, Francesco Paolo Colonna and Alessandro Bongini and has published in prestigious journals such as Hepatology, Advanced Drug Delivery Reviews and Analytical Biochemistry.

In The Last Decade

C. Busi

44 papers receiving 833 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Busi Italy 21 467 319 302 117 106 45 890
Anuradha Balasubramanian United States 17 365 0.8× 213 0.7× 212 0.7× 100 0.9× 80 0.8× 26 1.0k
Blaire L. Osborn United States 14 379 0.8× 155 0.5× 165 0.5× 130 1.1× 27 0.3× 26 830
Andrzej Piasek Poland 12 369 0.8× 178 0.6× 161 0.5× 24 0.2× 183 1.7× 23 785
Zhilei Chen United States 15 451 1.0× 74 0.2× 85 0.3× 72 0.6× 70 0.7× 41 808
Francesca Curreli United States 19 431 0.9× 143 0.4× 231 0.8× 184 1.6× 222 2.1× 38 1.2k
Joke Regts Netherlands 22 694 1.5× 73 0.2× 293 1.0× 155 1.3× 41 0.4× 36 1.4k
Sulaiman Shams Pakistan 16 194 0.4× 225 0.7× 153 0.5× 42 0.4× 109 1.0× 58 813
C. Shipman United States 11 207 0.4× 56 0.2× 256 0.8× 93 0.8× 100 0.9× 19 691
Ritu Shrestha United States 21 549 1.2× 89 0.3× 129 0.4× 200 1.7× 174 1.6× 36 1.3k
Yanming Du United States 21 434 0.9× 248 0.8× 371 1.2× 96 0.8× 290 2.7× 51 1.2k

Countries citing papers authored by C. Busi

Since Specialization
Citations

This map shows the geographic impact of C. Busi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Busi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Busi more than expected).

Fields of papers citing papers by C. Busi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Busi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Busi. The network helps show where C. Busi may publish in the future.

Co-authorship network of co-authors of C. Busi

This figure shows the co-authorship network connecting the top 25 collaborators of C. Busi. A scholar is included among the top collaborators of C. Busi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Busi. C. Busi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fiume, L., Michele Baglioni, C. Busi, Marcella Manerba, & Giuseppina Di Stefano. (2009). The enhancement of interstitial transport of a doxorubicin–lactosaminated albumin conjugate by imatinib: In rat hepatocellular carcinoma it is not preferentially higher than that in liver and bone marrow. European Journal of Pharmaceutics and Biopharmaceutics. 72(3). 630–631. 2 indexed citations
2.
Stefano, Giuseppina Di, L. Fiume, Michele Baglioni, et al.. (2008). Doxorubicin coupled to lactosaminated albumin: Effect of heterogeneity in drug load on conjugate disposition and hepatocellular carcinoma uptake in rats. European Journal of Pharmaceutical Sciences. 33(2). 191–198. 12 indexed citations
3.
Stefano, Giuseppina Di, L. Fiume, Michele Baglioni, et al.. (2006). A conjugate of doxorubicin with lactosaminated albumin enhances the drug concentrations in all the forms of rat hepatocellular carcinomas independently of their differentiation grade. Liver International. 26(6). 726–733. 22 indexed citations
4.
Stefano, Giuseppina Di, L. Fiume, Marco Domenicali, et al.. (2006). Doxorubicin coupled to lactosaminated albumin: Effects on rats with liver fibrosis and cirrhosis. Digestive and Liver Disease. 38(6). 404–408. 25 indexed citations
5.
Stefano, Giuseppina Di, L. Fiume, Michele Baglioni, et al.. (2006). Coupling of lactose molecules to the carrier protein hinders the spleen and bone marrow uptake of doxorubicin conjugated with human albumin. European Journal of Pharmaceutical Sciences. 30(2). 136–142. 10 indexed citations
6.
Fiume, L., Luigi Bolondi, C. Busi, et al.. (2005). Doxorubicin coupled to lactosaminated albumin inhibits the growth of hepatocellular carcinomas induced in rats by diethylnitrosamine. Journal of Hepatology. 43(4). 645–652. 43 indexed citations
7.
Stefano, Giuseppina Di, et al.. (2002). Conjugates of Nucleoside Analogs with Lactosaminated Human Albumin to Selectively Increase the Drug Levels in Liver Blood: Requirements for a Regional Chemotherapy. Journal of Pharmacology and Experimental Therapeutics. 301(2). 638–642. 7 indexed citations
8.
Stefano, Giuseppina Di, C. Busi, & L. Fiume. (2002). Floxuridine coupling with lactosaminated human albumin to increase drug efficacy on liver micrometastases. Digestive and Liver Disease. 34(6). 439–446. 20 indexed citations
9.
Stefano, Giuseppina Di, et al.. (2001). Coupling of 5-fluoro 2′-deoxyuridine to lactosaminated poly-l-lysine: an approach to a regional, non-invasive chemotherapy of liver micrometastases. Biochemical Pharmacology. 61(4). 459–465. 4 indexed citations
10.
11.
Stefano, Giuseppina Di, C. Busi, A Mattioli, et al.. (1999). Inhibition of [3H]thymidine incorporation into DNA of rat regenerating liver by 2′,2′-difluorodeoxycytidine coupled to lactosaminated poly-l-lysine. Biochemical Pharmacology. 57(7). 793–799. 12 indexed citations
12.
Fiume, L., Giuseppina Di Stefano, C. Busi, et al.. (1997). Liver targeting of antiviral nucleoside analogues through the asialoglycoprotein receptor. Journal of Viral Hepatitis. 4(6). 363–370. 33 indexed citations
13.
Stefano, Giuseppina Di, Francesco Paolo Colonna, Alessandro Bongini, et al.. (1997). Ribavirin conjugated with lactosaminated poly-l-lysine. Biochemical Pharmacology. 54(3). 357–363. 44 indexed citations
14.
Fiume, L., Giuseppina Di Stefano, C. Busi, et al.. (1997). Hepatotropic conjugate of adenine arabinoside monophosphate with lactosaminated poly-l-lysine. Journal of Hepatology. 26(2). 253–259. 23 indexed citations
15.
16.
Fiume, L., Giuseppina Di Stefano, C. Busi, & A Mattioli. (1994). A conjugate of lactosaminated poly-l-lysine with adenine arabinoside monophosphate, administered to mice by intramuscular route, accomplishes a selective delivery of the drug to the liver. Biochemical Pharmacology. 47(4). 643–650. 20 indexed citations
17.
Fiume, L., C. Busi, Giuseppina Di Stefano, & A Mattioli. (1993). Coupling of Antiviral Nucleoside Analogs to Lactosaminated Human Albumin by Using the Imidazolides of Their Phosphoric Esters. Analytical Biochemistry. 212(2). 407–411. 18 indexed citations
18.
Fiume, L., Christine M. Betts, C. Busi, et al.. (1992). The pathogenesis of vacuoles produced in rat and mouse liver cells by a conjugate of adenine arabinoside monophosphate with lactosaminated albumin. Journal of Hepatology. 15(3). 314–322. 12 indexed citations
19.
20.
Fiume, L., C. Busi, & A Mattioli. (1982). Lactosaminated human serum albumin as hepatotropic drug carrier. FEBS Letters. 146(1). 42–46. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anuradha Balasubramanian Breakdown of academic impact, for papers by Blaire L. Osborn Breakdown of academic impact, for papers by Andrzej Piasek Breakdown of academic impact, for papers by Zhilei Chen Breakdown of academic impact, for papers by Francesca Curreli Breakdown of academic impact, for papers by Joke Regts Breakdown of academic impact, for papers by Sulaiman Shams Breakdown of academic impact, for papers by C. Shipman Breakdown of academic impact, for papers by Ritu Shrestha Breakdown of academic impact, for papers by Yanming Du
Rankless by CCL
2026